Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Therapeutic mechanism of Yuxingeng liquid on early ventricular remodeling with acute myocardial infarction in rats
  
View Full Text  View/Add Comment  Download reader
KeyWord:Yuxingeng liquid  acute myocardial infarction  early ventricular remodeling
Author NameAffiliationE-mail
Shi Da-zhuo Xiyuan Hospital, China Academy of Traditional Chinese Medicine, 100091, Beijing shidz@public.fhnet.cn.net 
Liu Jian-gang Xiyuan Hospital, China Academy of Traditional Chinese Medicine, 100091, Beijing  
Dong Guo-ju Xiyuan Hospital, China Academy of Traditional Chinese Medicine, 100091, Beijing  
Hits: 1237
Download times: 486
Abstract:
      Objective: To examine the therapeutic mechanism of Yuxingeng liquid (YXGL) on early ventricular remodeling in Wistar rats with acute myocardial infarction(AMI).Methods: Measuring the cardiac index (CI), left ventricular weight (LVW) and cardiac myocyte dimension and observing the concentration of endothelin (ET) and angiotensin II (Ang II) in the plasma and myocardium. AMI models were established by ligature of left anterior descending coronary artery and the rats with AMI were randomly divided into 6 groups: the model group, sham-operation group, captopril group, high dosage YXGL group, middle dosage YXGL group and low dosage YXGL group. From the next day after modeling, the rats had been given YXGL through the gastric tube, which lasted for 4 weeks. And then, CI, LVW and concentration of ET and Ang II in the plasma and myocardium were tested.Results: Comparing with model control group, high dosage YXGL, middle dosage YXGL and captopril can all significantly reduce CI, LVW, cardiac cell dimension and content of ET and Ang II in both plasma and myocardium (P < 0.05 orP < 0.01).Conclusion: YXGL can remarkably reduce LVW, CI and concentration of ET and Ang II, and lowering the concentration of ET and Ang II is possibly one of the mechanisms intervening the pathological course of the early ventricular remodeling in rats with AMI. State Natural Science Fund (Approval No. 39870942)
Close